NR2F1 and cancer: In contrast to the bulk tumor results, TGFβ and cancer stem cell-related pathways were not enriched in NR2F1-positive cancer cells, and conversely, TGFβ signaling and Wnt/β-catenin signaling gene sets were suppressed in Cohort 1 (Figure 4 left).